Harvard Bioscience
HBIO · NASDAQ
$8.34+$0.25 (+3.09%)TodayMarket closed ·
Prev close $8.09
Who owns HBIO
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 40.2% of HBIO’s shares.
- Weber Capital Management, LLC6.9%
- AMH Equity, Ltd.6.5%
- Green (James W)4.6%
- Meros Investment Management, LP4.1%
- Next 6 largest institutions18.1%
- All other shareholders59.8%
| Holder | Shares | % of shares |
|---|---|---|
| Weber Capital Management, LLC | 310.86K | 6.89% |
| AMH Equity, Ltd. | 293.68K | 6.51% |
| Green (James W) | 207.76K | 4.61% |
| Meros Investment Management, LP | 182.99K | 4.06% |
| Acadian Asset Management LLC | 179.61K | 3.98% |
| Vanguard Capital Management, LLC | 169.63K | 3.76% |
| Florida State Board of Administration | 131.09K | 2.91% |
| Corsair Capital Management, L.P. | 122.81K | 2.72% |
| Two Sigma Investments, LP | 114.55K | 2.54% |
| Renaissance Technologies LLC | 99.33K | 2.20% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Florida State Board Administration Fund | 131.09K | 2.91% |
| Vanguard Total Stock Market Index Fund | 123.47K | 2.74% |
| Vanguard Extended Market Index Fund | 42.04K | 0.93% |
| Fidelity Extended Market Index Fund | 22.39K | 0.50% |
| Acuitas US Microcap Fund | 8.78K | 0.19% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of HBIO in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Eade Katherine A. | Award | 16.56K | — |
| Snider William | Award | 16.56K | — |
| DENELSKY STEPHEN J | Award | 16.56K | — |
| Gagnon Robert E. | Award | 16.56K | — |
| Benson Seth Benjamin | Award | 16.56K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 45.00K
- Days to cover
- 2.61
- % of shares outstanding
- 1.00%
- Average daily volume
- 17.22K
- Change since last report
- −6.5%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.